Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 50/100

Failure Rate

11.1%

48 terminated/withdrawn out of 433 trials

Success Rate

72.3%

-14.3% vs industry average

Late-Stage Pipeline

18%

78 trials in Phase 3/4

Results Transparency

6%

7 of 125 completed trials have results

Key Signals

29 recruiting7 with results26 terminated22 withdrawn

Enrollment Performance

Analytics

N/A
183(56.5%)
Phase 4
50(15.4%)
Phase 2
36(11.1%)
Phase 3
28(8.6%)
Phase 1
23(7.1%)
Early Phase 1
4(1.2%)
324Total
N/A(183)
Phase 4(50)
Phase 2(36)
Phase 3(28)
+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (433)

Showing 20 of 433 trials
NCT07681843Not ApplicableActive Not Recruiting

Early (Postoperative Day 3) Versus Standard (Postoperative Day 6) Urethral Catheter Removal After Living Donor Kidney Transplantation: A Prospective Randomized Controlled Trial

Role: collaborator

NCT07362992Early Phase 1Recruiting

Topical Tranexamic Acid to Reduce Blood Loss During Cesarean Delivery

Role: collaborator

NCT07173894Not ApplicableCompleted

Effectiveness of Field Block Compared With Interscalene Block in Shoulder Surgery

Role: lead

NCT03510078Not ApplicableCompleted

Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients

Role: lead

NCT07226089Phase 3Recruiting

Comparison of Weekly Somatrogon to Daily Genotropin in Children Born Small for Gestational Age or With Idiopathic Short Stature.

Role: lead

NCT03451968Not ApplicableRecruiting

Amino Acid Metabolism in Fed Surgical Critically Ill Patients

Role: lead

NCT07491874Not ApplicableNot Yet Recruiting

Use of Nitrous Oxide for Pain and Anxiety Management During Cervical Cerclage Removal

Role: collaborator

NCT05171725Completed

Multidisciplinary Expert System for the Assessment & Management of Complex Brain Disorders

Role: collaborator

NCT06837909Not ApplicableRecruiting

Transversus Abdominis Plane Block Versus Wound Infiltration for Pulmonary Function Preservation Following Laparoscopic Living Donor Nephrectomy

Role: lead

NCT06029244Not ApplicableCompleted

Eyecontrol coMmunication Platform for dEliRium manaGemEnt in Intensive Care Units (EMERGE)

Role: collaborator

NCT03774069Not ApplicableTerminated

The Advisor Pro Direct Study

Role: lead

NCT07208240Phase 1Recruiting

Tb-PSMA-I&T Radionuclide Before Radical Prostatectomy in Patients With Locally Advanced Prostate Cancer - TbeforePROST Trial.

Role: lead

NCT07131163Recruiting

Real World Stage II-III NSCLC Patients Receiving Neoadjuvant Chemo-immunotherapy and no Surgical Resection

Role: collaborator

NCT03671967Phase 4Recruiting

PipEracillin Tazobactam Versus mERoPENem for Treatment of Bloodstream Infections Caused by Cephalosporin-resistant Enterobacteriaceae (PETERPEN)

Role: collaborator

NCT05355350Phase 4Withdrawn

PipEracillin/Tazobactam Versus mERoPENem for Treatment of AmpC Producing Blood Stream Infections

Role: collaborator

NCT05627622Not ApplicableActive Not Recruiting

Effectiveness of WhatsApp Education and Support Messages for Urolithiasis Prevention

Role: lead

NCT05992363Not ApplicableRecruiting

Tandem Polyurethane Stents Compared to Single Silicone Stent for Malignant Ureteral Obstruction

Role: lead

NCT06729502Recruiting

Pictorial Fit-Frail Scale in Adults Admitted to the ICU in a Tertiary Center- an Observational Prospective Study

Role: lead

NCT06951399Phase 2Not Yet Recruiting

Tracking T-Cell Responses to Evaluate Pembrolizumab Effectiveness in Advanced Non-Small Cell Lung Cancer

Role: lead

NCT02805023Phase 1Active Not Recruiting

BGC101 (EnEPC) Autologous Cell Therapy From Patient's Own Blood for Treatment of Critical Limb Ischemia (CLI)

Role: collaborator